- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06058104
Evaluating Efficacy of a Digital Game Therapeutic for Children With Autism
May 13, 2025 updated by: Dennis Paul Wall, Stanford University
Evaluating Efficacy of a Digital Game Based Therapeutic for Improving Socialization Outcomes in Autistic Children, A Randomized Clinical Trial.
The following study aims to assess the efficacy of the game-based digital therapeutic, GuessWhat, in improving adaptive socialization skills in children with Autism Spectrum Disorder (ASD).
GuessWhat is a mobile application (available for free for iOS and Android) which contains a suite of games: pro-social charades, emotion guessing, and quiz.
Participant families will use their personal smartphones to download the app and play it with their child according to a predetermined regimen.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
The following study aims to understand the efficacy of the digital therapeutic, GuessWhat, in improving socialization outcomes in children with Autism Spectrum Disorder (ASD) after regular use over 8 weeks.
We will use a cross-over, waitlist control design to examine outcomes after 8 weeks.
GuessWhat is a mobile application (available for free for iOS and Android) which contains a suite of games: pro-social charades, emotion guessing, and quiz.
Participant families will use their personal smartphones to download the app and play it with their child according to a predetermined regimen.
The study will enroll parents who are at least 18 years old and have a child between 3 and 12 years old with a formal ASD diagnosis.
Parents will be asked to complete two clinical outcome measure questionnaires immediately prior to and up to 1 week after playing GuessWhat with their child 3 times per week for 8 weeks.
Study Type
Interventional
Enrollment (Estimated)
1000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kaiti Dunlap, MRes
- Phone Number: 650-497-9214
- Email: kdunlap2@stanford.edu
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Parent who is at least 18 years old of child with autism.
- Child with autism is between 3 and 12 years old at time of baseline data collection.
- A professional diagnosis of Autism that is able to be confirmed by negative score on a machine learning based algorithm using items from Mobile Autism Risk Assessment and video based classifier or by a copy of diagnostic report.
Exclusion Criteria:
- Parent is unable to read the app in the offered languages (English, Spanish, Portuguese)
- Parent does not have an Android or iOS smartphone compatible with GuessWhat App.
- Child has additional psychiatric or neurologic diagnoses including genetic syndromes or epilepsy in addition to autism.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Charades-based mobile digital therapeutic
The mobile app is a charades style game and app that engages parent and child in fluid social interaction where the parent must guess what the child is acting out based on the prompt shown on the phone screen.
Participants will use their own personal phone to download the study app.
Parents are asked to play with their child for 15 minutes 3-4 times per week for 8 weeks.
|
The mobile app is a charades style game and app that engages parent and child in fluid social interaction where the parent must guess what the child is acting out based on the prompt shown on the phone screen.
Participants will use their own personal phone to download the study app.
Parents are asked to play with their child 15 minutes 3-4 times per week for 8 weeks.
Other Names:
|
|
No Intervention: Treatment as Usual
Participants in control group will continue their Applied Behavior Analysis therapy as usual for 8 weeks, and then will be able to cross-over to the treatment condition at week 8.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in parent reported socialization based on the Vineland Adaptive Behavior Scales 3rd Edition (VABS-3) Parent/Caregiver Socialization Subscale, from baseline to week 8
Time Frame: Baseline (Week 0), Week 8
|
Vineland Adaptive Behavior Scales, 3rd edition (VABS-3) Socialization subscale of the Parent/Caregiver Comprehensive form will be administered online to the parents.
Scores from the socialization domain of the VABS-III reflects one's functioning in social situations.
The socialization subscale is up to 112 items depending on age and development, where raw scores are converted to Intellectual Quotient-type standard scores--v-scale scores (M=15, SD=3) where scores range from 1 to 24, and factor in age equivalents, growth scale values, and higher scores indicate better adaptive functioning.
|
Baseline (Week 0), Week 8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Parental Stress Scale - from baseline to week 8
Time Frame: Baseline (Week 0), Week 8
|
The Parental Stress Scale is an 18-item parent report scale that evaluates the extent of parent stress.
Scores range from 18-90, where higher scores indicate a higher level of Parental stress.
|
Baseline (Week 0), Week 8
|
|
Change in Emotion Recognition from baseline to week 8
Time Frame: Baseline (Week 0), Week 8
|
Study team will use an image based emotion recognition task where participants will select the emotion that corresponds to an emotional facial image in the form of a GIF (Graphics Interchange Format) image.
Participants will select 1 of 8 available Ekman emotion labels for 16 facial emotional image stimuli presented in random order.
Correct responses will be measured against a predetermined majority rules consensus of the emotional content of the GIFs.
|
Baseline (Week 0), Week 8
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
mobile autism risk assessment score at baseline
Time Frame: baseline (week 0)
|
Study team will use a level 2 screening tool that has been validated in several studies and that uses a brief parent/caregiver questionnaire with a 2 minute home video to generate a classification score that indicates severity of the autism phenotype (ranging from no autistic symptoms to severe autism) as well as confidence in the classification.
|
baseline (week 0)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Dennis P Wall, PhD, Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
October 1, 2025
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
December 1, 2026
Study Registration Dates
First Submitted
September 15, 2023
First Submitted That Met QC Criteria
September 21, 2023
First Posted (Actual)
September 28, 2023
Study Record Updates
Last Update Posted (Actual)
May 15, 2025
Last Update Submitted That Met QC Criteria
May 13, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 60181-Stanford
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Adia Med of Winter Park LLCRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
University of California, Los AngelesUniversity of WashingtonRecruitingAutism Spectrum Disorder (ASD)United States
Clinical Trials on Charades based mobile digital therapeutic
-
Dongtan Sacred Heart HospitalCompleted
-
University of South FloridaRecruitingPostpartum Pelvic Floor Function and SymptomsUnited States
-
Hedonia LtdCompletedDepressive Disorder | Depression | Major Depressive Disorder | Clinical DepressionUnited States
-
University of WashingtonNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Jinan University GuangzhouGuangzhou Women and Children's Medical CenterActive, not recruitingAdolescent Idiopathic Scoliosis (AIS)China
-
Kaohsiung Veterans General Hospital.Completed
-
BELL Therapeutics Inc.Not yet recruitingInsomnia | Sleep Initiation and Maintenance DisordersSouth Korea
-
University of Massachusetts, WorcesterJohns Hopkins University; National Institute of Nursing Research (NINR); National... and other collaboratorsCompletedTraumatic Brain Injury | Acute Ischemic Stroke | Hemorrhagic Stroke, IntracerebralUnited States
-
Ad scientiamCompleted
-
Oui Therapeutics, Inc.National Institute of Mental Health (NIMH); Florida State UniversityNot yet recruitingPTSD | Post Traumatic Stress Disorder